Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration ApprovalsGuruFocus · Oct 7, 2026
Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration ApprovalsBusiness Wire · Oct 7, 2026
Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026Business Wire · Sep 25, 2026
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire · Sep 16, 2026
Quanterix Names Dr. Yuri Fesko Chief Medical OfficerGuruFocus · Sep 14, 2026
Quanterix Names Dr. Yuri Fesko Chief Medical OfficerBusiness Wire · Sep 14, 2026Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's core offerings include several innovative instruments: The HD-X instrument, which provides highly sensitive and automated multiplex protein detection.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 10, 2026 | -$0.41 | -$1.04 | Miss |
| May 6, 2026 | -$0.31 | -$0.39 | Miss |
| Mar 2, 2026 | -$0.27 | -$0.38 | Miss |
| Nov 10, 2025 | -$0.23 | -$0.73 | Miss |
| Aug 7, 2025 | -$0.41 | -$0.77 | Miss |
| May 12, 2025 | -$0.69 | -$0.53 | Beat |